Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

CAMBRIDGE, MASSACHUSETTS – Dec. 15, 2021 –  Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-human clinical use of the only FDA cleared cold storage device…

Continue ReadingParagonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

First-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center

CAMBRIDGE, MASSACHUSETTS – December 1, 2021 – Paragonix Technologies, the leading hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska…

Continue ReadingFirst-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center